NCT01300039

Completed

Oral Antibiotic Treatment of Helicobacter Pylori Reduces Int...

VA New York Harbor Healthcare System Source

Compare

Other study identifiers

Sponsor study identifier

573

Study Type

observational

Actual enrollment (reported)

50

Locations

0 countries

Sites

N/A

Timeline

Study Start

January 2003

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

June 2008

Actual (reported)

Study Completion

June 2008

Actual (reported)

Brief Summary

The investigators are finding out if giving antibiotics for Helicobacter pylori will eliminate colonization of the colon by Oxalobacter formigenes.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 50 participants
Study completion date: June 2008
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2003
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
June 2008
Actual (reported)
Study Completion
June 2008
Actual (reported)
First Submitted
February 18, 2011
Actual (reported)
First Posted
February 21, 2011
Actual (reported)

Last Updated: February 21, 2011
Status Verified: February 2011
Last Update Submitted: February 18, 2011

Conditions

Nephrolithiasis

Keywords

nephrolithiasisurolithiasishyperoxaluriaHelicobacter pylori

Study Arms (2)

Antibiotics for H. pylori

Patients who underwent upper endoscopy and were found to have H. pylori, and were then to be treated with antibiotics for eradication of H. pylori

Control group, no H. pylori

Patients who underwent upper endoscopy and found to not have H. pylori, and then would not receive antibiotics

Eligibility Criteria

Age18 Years - 80 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients undergoing upper endoscopy for any indication and who would have determination of presence or absence of H. pylori. Stool samples then positive for colonization with Oxalobacter formigenes.

You may qualify if:

age 18-80 years old

Sponsors & Collaborators

VA New York Harbor Healthcare System
US federal agencylead

MeSH Terms

Conditions

NephrolithiasisUrolithiasisHyperoxaluria

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

David S Goldfarb, MD
New York Harbor VA Medical Center
PRINCIPAL INVESTIGATOR

Enrollment

50 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Sponsor Type: FED

Study Record Dates

First Submitted

February 18, 2011

First Posted

February 21, 2011

Study Start

January 2003

Date type not reported

This date has not been verified as actual or estimated.

The Success of Pediatric Percutaneous Nephrolithotomy

Not ApplicableCompleted

NCT03332056

The Use of Belladonna and Opium Suppository in the Treatment of Postoperative Stent Pain

Phase 4Completed

NCT03454139

Subcostal TAP Block For Percutaneous Nephrolithotomy

Not ApplicableCompleted

NCT07835113

Tissue Sensor for Semirigid Thulium Fiber Laser Ureterolithotripsy

Not ApplicableNot Yet Recruiting

NCT05924165

Narcotic-Free Percutaneous Nephrolithotomy

Phase 4Completed

NCT03379922

Strategies to Maximise Patient Comfort During ESWL

Not ApplicableCompleted

undergoing upper endoscopy

H. pylori present or absent on gastric histology

stool positive for Oxalobacter formigenes

You may not qualify if:

unable to consent
stool negative for Oxalobacter formigenes

Contact the study team to confirm eligibility.

Primary Completion

June 2008

Actual (reported)

Study Completion

June 2008

Actual (reported)

Last Updated

February 21, 2011

Record last verified: 2011-02

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01300039
Data provider: ClinicalTrials.gov
Source updated: 2011-02-21
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:21:15 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Study Arms (2)

Antibiotics for H. pylori

Control group, no H. pylori

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record